INmune Bio's ATM offering raises $19M ahead of Phase II results, but disappointing data and dilution signal risks. Read here ...

DelveInsight's Frontotemporal Dementia Market Insights report includes a comprehensive understanding of current treatment ...

Cassava Sciences (SAVA) announced that the Company presented a poster at the TSC International Research Conference held June 26-28, 2025 in ...

Data show that simufilam reduced seizure activity in a preclinical mouse model Presentation also highlights favorable human ...

Climate change is on track to reduce by 11 percent in 2100 the yields that today provide two-thirds of humanity's calories ...

About This EventCaris Life Sciences (Nasdaq: CAI), a leading next-generation AI TechBio company and precision medicine pioneer, visits the Nasdaq MarketSite in Times Square.In honor of the ...

Caris Life Sciences Inc., a health care company that uses technology to help diagnose and treat cancer, raised $494 million in a U.S. initial public offering that priced above the top of its ...

Caris Life Sciences (CAI) stock is expected to make its trading debut on Wednesday after the company priced its IPO at $21/share. Read more here.

BOLD TYPES At BIO convention, Healey offers upbeat message to life sciences crowd By Jon Chesto Globe Staff,Updated June 18, 2025, 11:39 a.m.

Thailand's leadership in the global cassava industry took centre stage at the Global Cassava Sustainability Forum 2025, held today at Pullman Bangkok King Power. Co-hosted by King Mongkut's University ...

To address this issue, our research team evaluated five improved cassava genotypes (PRO Vitamin A (PRVA), TME 419, TMS 98/0505, TMS 98/0581, and TMS 30572), all gotten from International Institute ...

On May 7, 2025, the American College of Rheumatology (ACR) released the full guideline for diagnosing, monitoring, and treating lupus nephritis (LN), which appeared in Arthritis & Rheumatology.